Using augmented reality for tracking during breast cancer surgery
Augmented Reality Feasibility for Non-invasive Preoperative Tracking in Breast Cancer Surgery
This study is testing if using augmented reality can help doctors see better during breast cancer surgery to make it less painful and reduce the chances of needing more surgery later.
Quick facts
| Phase | Not applicable |
|---|---|
| Study type | Interventional |
| Enrollment | 20 (estimated) |
| Ages | 18 Years to 100 Years |
| Sex | Female |
| Sponsor | Centre Jean Perrin Academic / other |
| Locations | 1 site (Clermont-Ferrand) |
| Trial ID | NCT06512558 on ClinicalTrials.gov |
What this trial studies
This study explores the feasibility of using augmented reality technology to enhance preoperative tracking for patients undergoing surgery for subclinical breast cancer lesions. The approach aims to replace traditional painful and invasive methods with a non-invasive system that provides real-time 3D visualization of the breast during surgery. By fusing preoperative imaging with live video, the goal is to improve surgical precision and reduce the need for repeat surgeries due to unhealthy margins. The study will involve additional MRI imaging with gadolinium and 3D camera imaging to facilitate this innovative guidance system.
Who should consider this trial
Good fit: Ideal candidates are adult women requiring conservative surgical management for a subclinical breast cancer lesion confirmed by histology.
Not a fit: Patients with breast neoplasia during pregnancy or those unable to provide informed consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly reduce patient discomfort and improve surgical outcomes in breast cancer surgeries.
How similar studies have performed: While augmented reality in surgical settings is a growing field, this specific application for breast cancer surgery is relatively novel and has not been extensively tested in prior studies.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Major women * Requiring conservative surgical management of a subclinical cancerous breast lesion (not palpable), the histology of which has been previously proven by anatomopathology; * Having a breast MRI indication at the time of the breast assessment performed at the Centre Jean Perrin * Ability to give informed consent to participate in the study, * Membership of a social security scheme Exclusion Criteria: * Patients with breast neoplasia during pregnancy; * Persons deprived of their liberty or under guardianship or incapable of giving consent; * Refusal to participate.
Where this trial is running
Clermont-Ferrand
- Centre Jean PERRIN — Clermont-Ferrand, France (Recruiting)
Study contacts
- Study coordinator: Céleste PINARD
- Email: Celeste.PINARD@clermont.unicancer.fr
- Phone: 0473278005
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.